Skip to main content
Home
Zeitschriften
Zeitungen
Podcast
Gesundheitspolitik
Praxis
Allerlei
Jobs
Fachgebiete
Allgemeinmedizin Anästhesiologie & Intensivmedizin Apotheke Augenheilkunde Chirurgie Dermatologie Gynäkologie und Geburtshilfe HNO Innere Medizin Kinder & Jugendheilkunde Neurologie & Psychiatrie Orthopädie & Unfallchirurgie Pflege Urologie Zahnmedizin
Subfächer Innere Medizin
Diabetologie Gastroenterologie Infektiologie Kardiologie Onkologie und Hämatologie Pneumologie Rheumatologie
Fortbildungen
Überblick Fortbildungen DFP-Literaturstudium-Artikel DFP-Webcast Fortbildungen DFP-Podcasts
Erweiterte Suche
Anmelden
nach oben
memo - Magazine of European Medical Oncology
Erschienen in:

01.09.2016 | editorial

A welcome statement from the associate Editor-in-Chief

verfasst von: Rupert Bartsch, MD

Erschienen in: memo - Magazine of European Medical Oncology | Ausgabe 3/2016

Einloggen, um Zugang zu erhalten

Excerpt

It is with great pleasure that I join the editorial team of memo – Magazine of European Medical Oncology – and take over the new position of the associate Editor-in-Chief. memo is a noteworthy journal that I have been reading with great interest for many years and which has without doubt benefitted my clinical practice. Indeed, there is one major difference between memo and the plethora of other publications in the field of oncology: Due to its timely and relevant articels covering the entire spectrum of hematology and oncology, and its series of short (but nevertheless comprehensive) reviews, memo is a journal which is actually read—and done so by a broad range of clinicians caring for cancer patients. …
Vorheriger Artikel Welcome to the new associate Editor-in-Chief of memo
Nächster Artikel ASH 2015—insights and outlooks
Metadaten
Titel
A welcome statement from the associate Editor-in-Chief
verfasst von
Rupert Bartsch, MD
Publikationsdatum
01.09.2016
Verlag
Springer Vienna
Erschienen in
memo - Magazine of European Medical Oncology / Ausgabe 3/2016
Print ISSN: 1865-5041
Elektronische ISSN: 1865-5076
DOI
https://doi.org/10.1007/s12254-016-0286-0

Weitere Artikel der Ausgabe 3/2016

Practice changing information in aggressive lymphoma, ASH 2015

  • short review

Welcome to the new associate Editor-in-Chief of memo

  • editorial

Focus on multiple myeloma at ASH 2015

  • short review

Healthcare resource utilization and G‑CSF use in patients with solid tumors or hematological malignancies hospitalized for febrile neutropenia in Bulgaria, Czech Republic and Slovakia

  • original report

Rationale of an economically driven PD1 biomarker development in lung cancer—an academic dilemma

  • editorial

Indolent lymphoma at ASH 2015: new treatment approaches

  • short review